IMMUTEP Ltd (IMMP) stock
IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
$3.48−0.17 (-4.79%)
Close on Nov 13, 2026Market cap $25.64MP/E –Yield –
Immutep profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2026 it was -328.1%, against -594.6% the year before. The highest annual figure on record is -81.6% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -328.1% | +266.5 |
| FY2025 | Jun 30, 2025 | -594.6% | −49.7 |
| FY2024 | Jun 30, 2024 | -545.0% | +222.3 |
| FY2023 | Jun 30, 2023 | -767.2% | −290.6 |
| FY2022 | Jun 30, 2022 | -476.6% | +276.9 |
| FY2021 | Jun 30, 2021 | -753.6% | −671.9 |
| FY2020 | Jun 30, 2020 | -81.6% | +163.3 |
| FY2019 | Jun 30, 2019 | -244.9% | −71.6 |
| FY2018 | Jun 30, 2018 | -173.3% | +48.6 |
| FY2017 | Jun 30, 2017 | -221.9% | +2834.7 |
| FY2016 | Jun 30, 2016 | -3056.6% | – |
See a number that looks wrong?